Phase I Trial of Oral PX-866
NCT00726583
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
PX-866
Sponsor
Cascadian Therapeutics Inc.